Shape Therapeutics Inc.

📍 Seattle, United States🗓 Founded 2018👥 146 employees💰 Last funded Apr 2024
Biotechnology Research🌐 shapetx.com
Website LinkedIn
ShapeTX is pioneering the field of programmable RNA medicines to repair the genetic causes of diseases. By merging innovations in AI and RNA technology to generate and analyze hundreds of billions of therapeutic possibilities, ShapeTX is developing breakthroughs in RNA editing, next-generation AAVs, and disruptive gene therapy manufacturing. The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer’s, Parkinson’s, and many more.
2
Total investors
1
Early stage
0
Mid stage
1
Late stage
2018
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Shape Therapeutics Inc.?
Shape Therapeutics Inc. has 2 investors on record on gritt.io, including 1 early-stage backers and 1 late-stage investors.
When did Shape Therapeutics Inc. last raise funding?
The most recent investment in Shape Therapeutics Inc. recorded on gritt.io was in April 2024.
When was Shape Therapeutics Inc. founded?
Shape Therapeutics Inc. was founded in 2018.
What industry is Shape Therapeutics Inc. in?
Shape Therapeutics Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Shape Therapeutics Inc. based?
Shape Therapeutics Inc. is headquartered in Seattle, United States.